secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001104659-26-027090
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dogwood Therapeutics shareholders approve warrant exercise for up to 4.4M shares
--------------------------------------------------------------------------------

- Proposal to approve potential exercise of warrant for 4,386,037 shares passed with 29,286,786 votes for, 19,057 against, 4,466 abstentions.
- Approval required under Securities Purchase Agreement dated Jan 11, 2026 and Nasdaq Listing Rule 5635(d).
- Adjournment proposal also approved with 29,283,790 for, 21,571 against.
- Quorum of 29,310,309 shares (88.03% of voting power) present at Special Meeting held March 11, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000110465926027090/0001104659-26-027090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000110465926027090/dwtx-20260311x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-027090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer